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Purpose: To investigate the anti-cancer properties of the methanol extract of Piper crocatum Ruiz & 
Pav. leaves and its mode of action in human breast cancer (T47D) cells.  
Methods: The anti-cancer property and mechanism of action of the extract were evaluated by its effect 
on cell viability, nuclear morphology, cell cycle progression and the expression of phosphorylated 
p44/p42 as a marker for cell proliferation.  
Results: The results showed that there was a reduction of cell viability by the extract in a concentration-
dependent manner and no alteration of nuclear morphology was observed. There were negligible 
changes in Sub-G1 phase formation after extract treatment. Expression of phosphorylated p44/42 was 
decreased by the extract only. Inclusion of the extract in the incubation medium decreased insulin-
stimulated phosphorylation of p44/p42 indicating that the anti-proliferative effect of the extract was via 
p44/p42 pathway.  
Conclusion: All together, the data indicate that P. crocatum methanol extract inhibits the growth of 
human breast cancer (T47D) cells via inhibition of p44/p42 phosphorylation.  
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INTRODUCTION 
 
Silymarin is an active extract of the seeds of 
Cancer is a major health problem and a 
leading cause of death not only in developed 
countries, but also in developing countries 
where approximately 72 % of all cancer death 
in the world occurred. Among women, breast 
cancer is the most commonly diagnosed 
cancer and frequent type of cancer causing 
death, resulting from metastatic spread of 
primary tumors
1
. Although common methods 
for cancer treatment have yielded some 
advantages, there is an ongoing need for 
both improvement of current therapeutic 
strategies and the search for novel agents.   
 
Throughout medical history, nature has long 
been shown an excellent and reliable source 
of new drugs, including anti-cancer agents. 
Approximately more than 60 % of currently 
used anticancer chemotherapeutics are 
derived in one way or another from natural 
sources, including plants
2,3
. In addition, there 
are more than 85,000 plant species that have 
been documented for medical use globally. 
The World Health Organization (WHO) 
estimates that almost 75 % of the world’s 
population has therapeutic experience with 
traditional remedies
4
. The major categories of 
plant-derived compounds that have medicinal 
properties are terpenoids, flavonoids, and 
alkaloids
5
. The origin of several cancer 
therapies currently being used are traceable 
to plants. Examples are vincristine and 
vinblastine from Catharanthus roseus
6
, taxol 
and docetaxel from Taxus brevifolia
7
, and 





Piper crocatum Ruiz and Pav. is traditionally 
used by Indonesians for treating various 
diseases, including breast cancer
9
. In East 
Borneo, from where the specimen for this 
study was collected, this plant is called 
Kerapakng Timang and people have 
empirically used it for curing cancer, which is 
traditionally named a deadly disease. To the 
best of our knowledge, however, there is no 
scientific evidence currently available 
regarding the anti-cancer properties of this 
plant. This, therefore, prompted us to 
investigate the anticancer properties of the 
methanol extract of the leaf of this plant on 
human breast cancer (T47D) cells as a model 
system. The biological activity of the extract 
was investigated in vitro by investigating cell 
viability, cellular and nuclear morphology, and 
examining sub-G1 portion after treatment 
with the extract. In addition, a study was also 
conducted to detect changes in the activity 
level of p44 and p42 mitogen-activated 
protein kinases (MAPKs; also known as 
extracellular signal-regulated protein kinases 
1 and 2 (ERK1/2)) when cells were exposed 
to the extract. The p44/p42 signaling was 
investigated since this signaling pathway has 
been associated with cell growth and 
represents an important target for anti-cancer 
therapy
10,11
. Some plant-derived products 









The leaves of Piper crocatum Ruiz & Pav. 
were collected from East Borneo forest by an 
exploration team from the Wood Chemistry 
Laboratory, Forestry Faculty, Mulawarman 
University, Samarinda, East Borneo, 
Indonesia and Stem Cell and Cancer Institute 
(SCI) Jakarta, Indonesia on March 2008. The 
plant was identified by Raharjo, of 
Dendrology Laboratory, Forestry Faculty, 
Mulawarman University, Indonesia and the 
voucher specimen (SCI-56) was deposited in 
the Wood Chemistry Laboratory, Forestry 
Faculty, Mulawarman University, Indonesia. 
 
The air-dried and ground leaves (10 g) were 
soaked in methanol (250 ml) for 24 h, and 
then the mixture was filtered to remove the 
marc. The extract was concentrated using 
rotary evaporator under vacuum at room 
temperature to obtain a final residue (1 g) for 
further experiment. The extraction was 
conducted at the Wood Chemistry 
Laboratory, Forest Product Department, 
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Forestry Faculty, Mulawarman University, 
Samarinda, East Borneo, Indonesia.  
 
Cell culture   
 
T47D cells were obtained from the 
Indonesian Institute of Sciences Research 
Centre for Chemistry, Natural Products, Food 
and Pharmaceuticals Division, Bandung, 
Indonesia. The cells were grown and 
maintained in Dulbecco’s Modified Eagle’s 
Medium (DMEM) with L-glutamine 
supplemented with 10 %v/v fetal bovine 
serum, sodium bicarbonate, 100 µg/ml 
streptomycin and 100 U/ml penicillin at 37
o
C 
in humidified atmosphere of 5 % CO2. 
 
Cell viability assay  
 
Cell viability was determined by a 
microculture tetrazolium teachnique (MTT) 
assay performed according to the method 
described by Arung et al
15
, with minor 
modifications. The MTT assay provides a 
quantitative measurement of viable cells by 
determining the amount of formazan crystals 
produced by metabolically active cells.  
Briefly, cells were seeded into a 96-well plate 
(5 x 10
3
 cells per well). After 24 h incubation, 
the medium was replaced with fresh medium 
containing leaf extract, dimethyl sulfoxide 
(DMSO; 1 %v/v in water), hydrogen peroxide 
(H2O2; 0.0014 %v/v in water) or medium 
alone and the cells were incubated for a 
further 24 h. DMSO (1 %v/v in water) was 
used as a negative control since this was 
used to re-suspend the extract. MTT reagent 
[3-(4,5-dimethyl-2.thiazolyl)-2,5-
diphenyltetrazolium bromide (10 µl) in PBS (5 
mg/ml)] was added to each well. The plate 
was incubated in a humidified atmosphere of 
5% CO2 at 37
o
C for 3 h and then the medium 
was discarded and formazan crystals were 
dissolved in  1.0 ml of 0.04 N HCl and 
incubated for 2 h. The absorbance of cells 
was measured at 570 nm by a microplate 
reader. Untreated cells were counted with a 
hemacytometer and used for interpolating the 
absorbance of MTT assay results. The data 
was presented as percentage of viable cells 
(%). The data was analysed with the two-
tailed student’s t-test against the untreated 
sample. 
 
Structural analysis and DAPI staining 
 
DAPI staining was performed as described by 
Sandra et al
16
 to determine the level of 
apoptosis in the cells. Briefly, the cells (5 × 
10
3
) were seeded onto sterilized cover slips 
in 60 mm Petri dish for 24 h and treated with 
the extract for another 24 h. Untreated cells 
and cells treated with DMSO (1%, v/v) and 
H2O2 (0.0014%, v/v) were used as controls. 
Treated cells and controls were rinsed with 
phosphate buffered saline (PBS), fixed with 
ice-cold 10% trichloroacetic acid, and further 
washed with cold 70, 80, 90 % and absolute 
ethanol. The cells were permeabilised with 
Triton-X (10 %v/v) and stained with 1 µg/ml 
4’-6-diamidino-2-phenylindole (DAPI) for 4 
min. To reduce the background, the stained 
cells were washed with PBS and were cover-
slipped with 90% glycerol and observed 
under a fluorescence microscope (Zeiss Axio 
Observer Z1, Göttingen, Germany). 
 
Sub-G1 apoptosis assay and flow 
cytometry 
 
The cells were separated into four treatment 
groups as mentioned in the cell viability 
assay section above and analyzed for sub-
G1 apoptosis using the method described by 
Sandra et al
16
. Briefly, the cells were seeded 
into a 24-well plate (25 x 10
3
 cells per well) 
and incubated for 24 h. The medium was 
then replaced with fresh medium containing 
the extract, DMSO, H2O2 or medium alone. 
After 24 h, the cells were harvested and 
suspended in 1 ml of hypotonic fluorochrome 
solution (50 µg/ml propidium iodide in 0.1% 
sodium citrate containing 0.1% Triton X-100). 
The cell suspensions were placed in the dark 
for 1-2 h at 4
o
C before flow cytometric 
analysis. The propidium iodide fluorescence 
of individual nuclei was measured using 
FACS Calibur facility (Becton Dickinson, San 
Jose, California). 
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Immunoblotting 
 
Western blot was performed as described 
previously by Sandra et al
16
. For 
immunoblotting, the various cell treatments 
investigated were: (i) cells treated with the 
extract (50 µg/ml) for 2 h; (ii) cells treated 
with insulin (1µg/ml) and harvested after 10 
and 30 min later; and (iii) cells treated with 
the extract (50 µg/ml) for 2 h in addition to 
insulin (1µg/ml) observed at 10 and 30 min 
after insulin treatment. Untreated cells were 
also observed as negative control. The 
untreated and treated cells were lysed with 
buffer [20 mM HEPES buffer pH 7.2, 150 mM 
NaCl, 2 mM EDTA, 1 % Triton X-100, 50 mM 
sodium fluoride, 2mM sodium orthovanadate, 
30 mM sodium pyrophosphate and a cocktail 
of protease inhibitors (containing 10 µM 
pepstatin A, 10 µM leupeptin and 1 mM p-
amidinophenyl methanesulfonyl fluoride; 
Sigma)] and scraped. Protein concentration 
was determined using the Bio-Rad protein 
assay kit (Bio-Rad, CA, USA). Proteins from 
cells were separated by 10% sodium dodecyl 
sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) and transferred to a 
polyvinylidene difluoride (PVDF) membrane. 
Equal loading of proteins was routinely 
ascertained by Ponceau S staining. After 
blocking with 5% skim milk in Phospate-
bufferred saline (PBS, pH 7.2), the 
membrane was incubated in 1 : 1,000 diluted 
rabbit polyclonal anti-phospho-p44/42 MAP 
Kinase (Thr202/Tyr204; Cell Signalling 
Technology, MA, USA), or 1 : 1,000 diluted 
mouse monoclonal anti-β-actin antibodies 
(Santa Cruz Biotechnology, CA, USA). The 
secondary antibody used was 1: 1,000 
diluted horseradish-peroxidase-conjugated 
goat anti-rabbit (Cell Signalling Technology, 
MA, USA) or 1:2000 diluted anti-mouse 
(Santa Cruz Biotechnology, CA, USA) IgG 
antibodies. The bound antibodies were 
visualized by G:Box Syngene System 







The IC50 (median inhibition concentration) is 
the concentration of toxic compound that 
reduces the biological activity by 50 %. The 
IC50 value was obtained from the MTT assay 
and calculated using non-linear regression 
analysis in Microsoft Excel software. The 
value was expressed as a geometric mean. 
Differences were considered to be 





Cytotoxic effects of leaf extract in T47D 
cells 
 
The results of the assessment of the 
cytotoxic effect of various extract 
concentrations of Piper crocatum leaf (5, 10, 
20 and 50 µg/ml) on T47D cells after 24 
exposures, determined by MTT assay, are 
shown in Figure 1. Cells with media only 
(untreated) and with added DMSO were also 
measured as negative controls, while cells 
treated with H2O2 was used as a positive 
control. A concentration-dependent decrease 
in cell viability was observed due to extract 
treatment, while only a small decrease (< 
20%) in cell viability occurred when cells 
were treated with DMSO, the solvent used to 
re-suspend the extract. IC50 was reached at a 




Figure 1: Effect of Piper crocatum leaf extract on 
T47D cell viability. (Treatments significantly 
differed from the untreated at *p < 0.05, **p < 
0.01).  
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Figure 2:  DAPI-stained T47D cells treated with 
Piper crocatum leaf extract. (A = untreated T47D 
cells (5 × 10
3
); B = cells treated with DMSO (1%, 
v/v); C = H2O2; and D = cells treated with the leaf 
extract at concentrations of 25 µg/ml (D). 
Apoptotic cells are indicated by arrows) 
 
Cell and nuclear morphology  
 
Based on MTT assay results, DAPI staining 
was conducted to investigate whether the leaf 
extract reduced cell viability by inducing 
apoptosis, which is indicated by the 
appearance of nuclear fragmentation and 
changes in cell morphology. As seen in 
Figure 2, the cells with no extract treatment 
(Figure 2 A) and cells treated with DMSO and 
the extract (Figures 2 B and D) showed 
similar cell and nuclear morphology, and 
apparently, there was no indication of 
apoptosis. On the other hand, the cells 
treated with H2O2 (Figure 2 C) showed 
nuclear fragmentation and cell morphology 
changes, indicating apoptosis (indicated by 
arrows). Although there was no apoptosis, it 
appeared that the extract inhibited the growth 
of the cells (compare Figure 2 A and B with 
Figure 2 D).  
 
Sub-G1 apoptosis  
 
To further verify that the leaf extract did not 
cause cell apoptosis, flow cytometric analysis 
of cells stained with propidium iodide was 
conducted. The results confirmed that there 
was no nuclear fragmentation, indicative of 
apoptosis, in cells as shown by negligible 
changes in sub-G1 portion after treatment 
with the extract. Sub-G1 fraction in the cells 
without treatment was 0.49 % (Figure 3 A), 
while those treated with H2O2 (positive 
control) was 83.04 % (Figure 3 B). After 
treatment with 25 and 50 µg/ml of the extract, 
sub-G1 fractions formed were 1.66 and 4.23 




Since leaf extract apparently may not cause 
apoptosis, the mechanism of the 
antiproliferative effect of the extract was 
investigated by examining the expression of 
activated p44/p42 proteins. Transmission of 
insulin signal in cell proliferation was detected 
also via p44/p42 activation (Capeau, 2003), 
and therefore, treatment cells with insulin 
were also conducted as a control. 
 
Figure 4 shows that T47D cells exposed to 
50 µg/ml of the leaf extract appeared to 
decrease p44/p42 activities compared to the 
untreated, as indicated by almost undetected 
signal intensity in the treated cells, while 
weak signals appeared in the untreated. Cells 
treated with insulin at 1 µg/ml caused 
transient p44/p42 activation, which confirms 
the involvement of p44/p42 in transmitting 
insulin signal (Figure 4). Inclusion of 50 µg/ml 
of the leaf extract in the incubation medium 
decreased expression of insulin-stimulated 
phosphorylation of p44/p42 at 10 and almost 





Today, cancer remains one of the leading 
causes of death around the globe. Various 
cancer therapies have currently been tried, 
including the use of natural products from 
higher plants. Therefore, there is an urgent 
need to discover an effective, novel and 
scientifically reliable natural compound. 
Furthermore, an understanding of the 
mechanism of an anti-cancer agent is also 





Wicaksono et al  







 A    B 
            
 










             
                      
 
Figure 3: Effect of Piper crocatum leaf extract on sub-G1 portion. (A = untreated T47D cells (25 X 10
4
) B = 
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Figure 4: Immunoblotting analysis to examine the 
effect of insulin and Piper crocatum leaf extract on 
T47D cells.  Note: Cell extracts from untreated 
(Unt) and treated with insulin (Ins) observed 10 and 
30 min, respectively; treated with the extract (Extr) 
at the concentration of 50 µg/ml and treated with 
leaf extract and insulin blotted using polyclonal 
antibody against phosphorylated p44/p42 (top 
panel) and using monoclonal antibody against β-
actin (lower panel). 
 
The extract reduced cell viability in a 
concentration-dependent fashion as shown in 
the MTT studies. Proliferation of T47D cells 
exposed to the leaf extract was potently 
inhibited compared to the unexposed cells, 
based on microscopic studies (data not 
presented in this work) and no cell apoptosis 
was observed as examined by DAPI staining 
and sub-G1 apoptosis assay using flow 
cytometry.  
 
Intracellular target of methanolic extract of P. 
crocatum leaves was further explored by 
examining the activity level of protein tyrosine 
kinase, p44/p42. Denhard
10
 and Seger and 
Krebs
11 
explained that p44/p42 is a central 
player in Ras/MAPK cascade that regulate cell 
growth, differentiation and survival. T47D cells 
exposed to 50 µg/ml of P. crocatum leaf 
extract decreased p44/p42 activities. This 
result is similar to that reported by Daniels et 
al
12
 which indicated that aqueous and ethanol 
extracts of Anemopsis californica at a 
concentration of 50 µg/ml decreased ERK1/2 
activities in human MCF-7/AZ breast and 
HCT8/E11 colon cancer cells. This activity 
might be responsible for the growth inhibitory 
effect of the extract in the cancer cells tested. 
Van Slambrouck et al
14
 also showed that cell 
growth was inhibited and levels of ERK1/2 
were decreased when MCF-7/AZ breast 
cancer cells were exposed to the aqueous 
extract of J. communis. Hollosy and Keri
18
 
also reported that many natural protein 
tyrosine kinase inhibitors have been derived 
from plants.  
 
The transmission of insulin signal in cell 
proliferation was known via p44/p42 
activation
17
. This study shows that insulin 
transiently stimulated p44/p42 activation. This 
result supports the data previously reported by 
Pawelczyk et al
19
. They reported that 
exposure of lymphocytes to insulin produced a 
transient increase in ERK1/2 phosphorylation, 
indicated by a significant increase of activated 
ERK1/2 at 1 and 5 min, and then a decrease 
at 15 and 30 min.  
 
To investigate whether the P. crocatum leaf 
extract have consistent inhibitory effect on 
p44/p42 phosphorylation, we examined the 
response of insulin-stimulated phosphorylation 
of p44/p42 to extract treatment. The data 
showed that apparently, the extract inhibited 
activation of insulin-stimulated 
phosphorylation of p44/p42, indicated by 
decreasing phosphorylation of these proteins 
after 10 min and virtual absence of a 
detectable signal after 30 min. These data 
confirm that P. crocatum leaf extract inhibited 





The results suggested that Piper crocatum 
Ruiz & Pav. leaf extract inhibited proliferation 
of human breast cancer (T47D) cells. No 
apoptosis was observed due to Piper 
crocatum leaf extract treatment. Intracellular 
mechanism examination suggested that the 
extract inhibited cancer cell growth via 
p44/p42-dependent way. Components 
consisted of this extract, therefore, may have 
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promise for use as a cancer chemotherapeutic 
agent in the future and can be used as 
scientific evidence to support anti-cancer 
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